Developmental toxicity of soman in rats and rabbits.
Soman (GD; phosphonofluoridic acid, methyl-,1,2,2-trimethylpropyl ester) is an organophosphate compound with potent anticholinesterase activity. To determine developmental toxicity, soman was administered orally to CD rats on days 6 through 15 of gestation at dose levels of 0, 37.5, 75, 150, or 165 micrograms/kg/day and to New Zealand White (NZW) rabbits on days 6 through 19 of gestation at dose levels of 0, 2.5, 5, 10, or 15 micrograms/kg/day. At sacrifice, gravid uteri were weighed and examined for number and status of implants. Individual fetal body weights and external, visceral, and skeletal malformations were recorded. Mean maternal weight changes, fetal implantation status/litter, fetal weight, and fetal malformations/litter were compared between dose groups. Monitors for maternal toxicity were net body weight change, treatment weight change, mortality, and clinical signs of toxicity such as lethargy, ataxia, and tremors. Maternal rats and rabbits in the high-dose groups exhibited statistically significant increases in toxicity and mortality when compared to controls. There were no significant dose-related effects among dose groups in the prevalence of postimplantation loss, malformations, or in average body weight of live fetuses per litter. There was no evidence of increased prenatal mortality or fetal toxicity in the CD rat or NZW rabbit following exposure to soman, even at a dose that produced significant maternal toxicity.
Bates
H K
HK
Pathology Associates, Inc., Jefferson, Arkansas.
LaBorde
J B
JB
Dacre
J C
JC
Young
J F
JF
D000818:Animals; D001835:Body Weight; D047108:Embryonic Development; D005260:Female; D005333:Fetus / Q000187:drug effects; D008098:Litter Size; D008297:Male; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D011817:Rabbits; D051381:Rats; D012999:Soman / Q000633:toxicity*; D013723:Teratogens
D013723:Teratogens; D012999:Soman